Safinamide Renal Impairment Trial

NCT01374113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: 50mg safinamide

Sponsor

Newron Pharmaceuticals SPA